FrancophonIA/ELRC3.0 huggingface dataset:
English: Once-a-day dosing of Tadalafil Lilly both for the treatment of erectile dysfunction and benign prostatic hyperplasia has not been evaluated in patients with hepatic impairment; therefore, if prescribed, a careful individual benefit/risk evaluation should be undertaken by the prescribing physician (see sections 4.4 and 5.2).
Maltese: Dożaġġ ta' darba kuljum ma ġiex evalwat f'pazjenti b'indeboliment epatiku; għalhekk jekk jiġi miktub mit-tabib, dan għandu jagħmel evalwazzjoni bir-reqqa tal-benefiċċju/riskju għal kull pazjent (ara sezzjonijiet 4.4 u 5.2).
English: Caution should be exercised when prescribing Tadalafil Lilly to patients using potent CYP3A4 inhibitors (ritonavir, saquinavir, ketoconazole, itraconazole, and erythromycin) as increased tadalafil exposure (AUC) has been observed if the medicinal products are combined (see section 4.5).
Maltese: Wieħed għandu joqgħod attent meta jikteb riċetta għal Tadalafil Lilly lill-pazjenti li qed jużaw inibituri qawwijin ta' CYP3A4 (ritonavir, saquinavir, ketoconazole, itraconazole, u erythromycin)
English: Therefore, administration of Tadalafil Lilly to patients who are using any form of organic nitrate is contraindicated (see section 4.3).
Maltese: Għalhekk lgħoti ta' Tadalafil Lilly lil pazjenti li qed jużaw kwalunkwe forma ta' nitrat organiku huwa kontra indikat (ara sezzjoni 4.3).
English: Tadalafil Lilly has been shown to improve these urinary symptoms as early as 1-2 weeks after starting treatment.
Maltese: Intwera li Tadalafil Lilly jista' jtejjeb dawn is-sintomi urinarji kmieni mill-1-2 ġimgħa mill-bidu tal-kura.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/17/1177/005
Maltese: FIS-SUQ EU/1/17/1177/005
English: NAME OF THE MEDICINAL PRODUCT Tadalafil Lilly 20 mg tablets tadalafil
Maltese: Kull pillola fiha 20 mg tadalafil
English: Tadalafil Lilly, should be used with caution in patients with anatomical deformation of the penis (such as angulation, cavernosal fibrosis or Peyronie's disease), or in patients who have conditions which may predispose them to priapism (such as sickle cell anaemia, multiple myeloma or leukaemia).
Maltese: Tadalafil Lilly għandu jintużab'kawtela f'pazjenti b'diformazzjoni anatomika tal-pene (bħal angolazzjoni, fibrozi kavernożali jew il-marda ta' Peyronie), jew f'pazjenti li għandhom kundizzjonijiet li jistgħu jippredisponuhom għal prijapiżmu (bħal sickle cell enemija, majeloma multipla jew lewkimja).
English: NAME OF THE MEDICINAL PRODUCT Tadalafil Lilly 2.5 mg tablets tadalafil
Maltese: Kull pillola fiha 2.5 mg tadalafil
English: There is limited clinical data on the safety of Tadalafil Lilly in patients with severe hepatic impairment (Child-Pugh Class C); if prescribed, a careful individual benefit/risk evaluation should be undertaken by the prescribing physician.
Maltese: Hemm informazzjoni klinika limitata dwar is-sigurta' ta' teħid ta' doża waħda ta'Tadalafil Lilly f'pazjenti b'insuffiċjenza severa tal-fwied (Child-Pugh Klassi C); It-teħid ta' doża darba kuljum ma ġietx evalwata f'pazjenti b'insuffiċjenza epatika.
English: In the primary efficacy studies of general populations, 81 % of patients reported that Tadalafil Lilly improved their erections as compared to 35 % with placebo.
Maltese: Fl-istudji dwar effikaċja primarja ta' popolazzjonijiet ġenerali, 81% tal-pazjenti sabu illi Tadalafil Lilly tejjeb l-erezzjonijiet tagħhom meta mqabbel ma' 35% li ħadu l-plaċebo.
English: NAME OF THE MEDICINAL PRODUCT Tadalafil Lilly 10 mg tablets tadalafil
Maltese: Kull pillola fiha 10 mg tadalafil
English: March 2017
Maltese: Data tal-ewwel awtorizzazzjoni: 22 Marzu 2017
English: In clinical trials with tadalafil 5 mg taken once a day for the treatment of benign prostatic hyperplasia, dizziness and diarrhoea were reported more frequently in patients over 75 years of age.
Maltese: F'studji kliniċi b'tadalafil 5 mg meħud darba kuljum għall-kura tal-iperplażja beninna tal-prostata, l-isturdament u d dijarea ġew irrapportati b'mod aktar frekwenti f'pazjenti 'l fuq minn 75 sena.
English: Tadalafil Lilly and other treatments for erectile dysfunction The safety and efficacy of combinations of Tadalafil Lilly and other PDE5 inhibitors or other treatments for erectile dysfunction have not been studied.
Maltese: Tadalafil Lilly u trattamenti oħra għal disfunzjoni erettili Is-sigurtà u l-effikaċja ta' l-użu flimkien ta' Tadalafil Lilly u inibituri oħrajn ta' PDE5 jew trattamenti oħra għall-kura tad-disfunzjoni erettili ma ġewx studjati.
English: Tadalafil Lilly has been shown to increase the effects of these medicines.
Maltese: Tadalafil Lilly intwera li jżid l-effetti ta' dawn il-mediċini.
English: Tadalafil is also > 10,000-fold more potent for PDE5 than for PDE7 through PDE10.
Maltese: Tadalafil huwa wkoll > 10,000 darba aktar potenti għal PDE5 milli għal
English: Method of administration Tadalafil Lilly is available as 2.5, 5, 10, and 20 mg film-coated tablets for oral use.
Maltese: Metodu ta' kif għandu jingħata Tadalafil Lilly hu disponibbli bħala pilloli miksija b'rita ta' 2.5, 5, 10 u 20mg għall-użu orali.
English: In patients receiving concomitant antihypertensive medicinal products, tadalafil 20 mg may induce a blood pressure decrease, which (with the exception of alpha blockers -see above-) is, in general, minor and not likely to be clinically relevant.
Maltese: F'pazjenti li jirċievu prodotti mediċinali għall-pressjoni għolja flimkien ma' tadalafil 20 mg, dan jista' jinduċi tnaqqis fil-pressjoni tad-demm, li (bl-eċċezzjoni ta' imblokkaturi tar-riċetturi alpha -ara hawn fuq-) huwa ġeneralment ħafif u x' aktarx ma jkunx klinikament rilevanti.
English: The most commonly reported adverse reactions in patients taking Tadalafil Lilly for the treatment of erectile dysfunction or benign prostatic hyperplasia were headache, dyspepsia, back pain and myalgia, in which the incidences increase with increasing dose of Tadalafil Lilly.
Maltese: L-aktar reazzjonijiet avversi komuni li ġew irrapportati f'pazjenti li qed jieħdu Tadalafil Lilly għallkura tad- disfunzjoni erettili jew għall-iperplażja beninna tal-prostata kienu uġigħ ta' ras, dispepsja, uġigħ fid-dahar u majalġja, fejn l-inċidenza tagħhom tiżdied hekk kif tiżdied id-doża ta' Tadalafil Lilly.
English: Tadalafil Lilly 10 mg film-coated tablets Light yellow and almond shaped tablets, marked "C 10" on one side.
Maltese: Kif jidher Tadalafil Lilly u l-kontenut tal-pakkett Tadalafil Lilly 10 mg hija pillola safra ċara miksija b'rita, f'forma ta' lewża u huma mmarkata b'"C
English: If you have taken or are planning to take Tadalafil Lilly, avoid excessive drinking (blood alcohol level of 0.08 % or greater), since this may increase the risk of dizziness when standing up.
Maltese: Jekk ħadt jew ser tieħu Tadalafil Lilly, evita li tixrob alkoħol eċċessiv (livell ta' alkoħol fid-demm ta' 0.08% jew aktar), minħabba li dan jista' jżid ir-riskju ta' sturdament meta tkun bil-wieqfa.
English: How to take Tadalafil Lilly
Maltese: X'fih Tadalafil Lilly
English: How to store Tadalafil Lilly
Maltese: Jekk tinsa tieħu Tadalafil Lilly
English: Do not take Tadalafil Lilly if you are already taking nitrates.
Maltese: Tiħux Tadalafil Lilly jekk diġà qed tieħu n-nitrati.
English: Facial oedema2,
Maltese: CYP2C19.
English: • if you are overweight;
Maltese: It-tabib tiegħek jista' jiddeċiedi li [isem ivvintat] jeħtieġ li jitwaqqaf.
English: VTE may be fatal in 1-2% of cases.
Maltese: VTE jista' jkun fatali f'1-2% tal-każijiet.
English: vision
Maltese: vista
English: • chest pain, discomfort, pressure, heaviness
Maltese: • uġigħ fis-sider, skumdità, pressjoni, toqla
English: [VTE or ATE should be listed in the adverse events table, under the frequency “Rare”.]
Maltese: [VTE jew ATE għandhom jiġu elenkati fit-tabella tal-avvenimenti avversi, taħt il-frekwenza "Rari".]
English: • severe dyslipoproteinaemia
Maltese: • dislipoproteinimja severa
English: Other medical conditions associated with adverse vascular events
Maltese: Kondizzjonijiet mediċi oħrajn assoċjati ma' avvenimenti vaskulari avversi
English: Temporary symptoms suggest the event is a transient ischaemic attack (TIA).
Maltese: Sintomi temporanji jissuġġerixxu li l-avveniment ikun attakk iskemiku temporanju (TIA - transient ischaemic attack).
English: The product information shall be subsequently updated by the Member State competent authorities and in liaison with the Reference Member State for medicinal product(s) authorised under Chapter 4 of Title III of Directive 2001/83/EC.
Maltese: L-informazzjoni tal-prodott għandha tiġi aġġornata sussegwentement mill-awtoritajiet kompetenti talIstati Membri u flimkien mal-Istat Membru ta' Referenza għall-prodott(i) mediċinali awtorizzat(i) taħt Kapitlu 4 ta' Titolu III ta' Direttiva 2001/83/KE.
English: Hypertension
Maltese: Puplesija
English: Arterial thromboembolic events may be fatal.
Maltese: Avvenimenti tromboembolitiċi fl-arterji jistgħu jkunu fatali.
English: Table: Risk factors for VTE
Maltese: Tabella: Fatturi ta' riskju għal VTE
English: About 9-12 out of 10,000 women
Maltese: Madwar 9-12 minn kull 10,000 mara
English: About 2 out of 10,000 women
Maltese: 10,000 mara
English: Cancer, systemic lupus erythematosus, haemolytic uraemic syndrome, chronic inflammatory bowel disease (Crohn's disease or ulcerative colitis) and sickle cell disease
Maltese: Kanċer, lupus eritematuż sistemiku, sindrome uremiku emolitiku, mard infjammatorja kroniku talimsaren (il-marda ta' Crohn jew kolite ulċerattiva) u marda taċ-ċelluli sickle
English: Possible side effects
Maltese: Sezzjoni 4 Effetti sekondarji possibbli
English: - sharp chest pain;
Maltese: • jekk għandek piż żejjed;
English: Particularly important in women with additional risk factors
Maltese: Importanti ħafna f'nisa b'fatturi ta' riskju addizzjonali.
English: ANNEX III.A - chlormadinone containing combined hormonal contraceptives
Maltese: ANNESS III.A - kontraċettivi ormonali kombinati li fihom chlormadinone
English: Obesity (body mass index over 30 kg/m2)
Maltese: Ħxuna żejda (indiċi tal-piż tal-ġisem ta' iktar minn 30 kg/m2)
English: • if you are very overweight (body mass index or BMI over 30kg/m2);
Maltese: • jekk għandek ħafna piż żejjed (indiċi tal-massa tal-ġisem jew BMI ta' iktar minn 30 kg/m2);
English: • Presence or risk of venous thromboembolism (VTE) o Venous thromboembolism - current VTE (on anticoagulants) or history of (e.g. deep venous thrombosis [DVT] or pulmonary embolism [PE]) o Known hereditary or acquired predisposition for venous thromboembolism, such as APC-resistance, (including Factor V Leiden), antithrombin-III-deficiency, protein C deficiency, protein S deficiency o Major surgery with prolonged immobilisation (see section 4.4) o A high risk of venous thromboembolism due to the presence of multiple risk factors (see section 4.4)
Maltese: • Preżenza jew riskju ta' tromboemboliżmu fil-vini (VTE - venous thromboembolism) o Tromboemboliżmu fil-vini - VTE kurrenti (fuq sustanzi kontra il-koagulazzjoni tad-demm) jew storja medika ta' (eż. trombożi fil-vini tal-fond [DVT - deep venous thrombosis] jew emboliżmu pulmonari [PE - pulmonary embolism]) o Predispożizzjoni ereditarja magħrufa jew predispożizzjoni akkwiżita għal tromboemboliżmu fil-vini, bħal reżistenza għall-APC (li tinkludi Fattur V Leiden), defiċjenza ta' antithrombin-III, defiċjenza ta' proteina Ċ, defiċjenza ta' proteina S o Operazzjoni maġġuri b'immobilizzazzjoni fit-tul (ara sezzjoni 4.4) o Riskju għoli ta' tromboemboliżmu fil-vini minħabba l-preżenza ta' fatturi ta' riskju multipli (ara sezzjoni 4.4)
English: Diabetes mellitus, hyperhomocysteinaemia, valvular heart disease and atrial fibrillation, dyslipoproteinaemia and systemic lupus erythematosus.
Maltese: Dijabete mellitus, iperomoċisteinimja, mard tal-valvs tal-qalb u fibrillazzjoni atrijali, dislipoproteinimja u lupus eritematuż sistemiku.
English: Hypertriglyceridaemia has been associated with an increased risk of developing pancreatitis (inflammation of the pancreas);
Maltese: Ipertrigliċeridemija ġiet assoċjata ma' żieda fir-riskju li tiżviluppa pankreatite (infjammazzjoni tal-frixa);
English: • Presence or risk of arterial thromboembolism (ATE) o Arterial thromboembolism - current arterial thromboembolism, history of arterial thromboembolism (e.g. myocardial infarction) or prodromal condition (e.g. angina pectoris) o Cerebrovascular disease - current stroke, history of stroke or prodromal condition (e.g. transient ischaemic attack, TIA) o Known hereditary or acquired predisposition for arterial thromboembolism, such as hyperhomocysteinaemia and antiphospholipid-antibodies (anticardiolipin-antibodies, lupus anticoagulant).
Maltese: • Preżenza jew riskju ta' tromboemboliżmu fl-arterji (ATE - arterial thromboembolism) o Tromboemboliżmu fl-arterji - tromboemboliżmu fl-arterji kurrenti, storja medika ta' tromboemboliżmu fl-arterji (eż. infart mijokardijaku) jew kondizzjoni prodromika (eż. anġina pectoris) o Mard ċerebrovaskulari - puplesija kurrenti, storja medika ta' puplesija jew kondizzjoni prodromika (eż. attakk iskemiku temporanju, TIA - transient ischaemic attack) o Predispożizzjoni ereditarja magħrufa jew predispożizzjoni akkwiżita għal tromboemboliżmu fl-arterji, bħal iperomoċistejnimja u antikorpi kontra l-fosfolipidi (antikorpi kontra cardiolipin, antikoagulant ta' lupus).
English: Limited epidemiological data suggest that the risk of VTE with dienogest-containing CHCs may be similar to the risk with levonorgestrel-containing CHCs.
Maltese: Dejta epidemoloġika limitata tindika li r-riskju ta' VTE b'CHCs li fihom dienogest jista' jkun simili għarriskju b'CHCs li jkun fihom levonorgestrel.
English: [*For the printed material, please refer to the guidance of the annotated QRD template.]
Maltese: [*Għall-materjal stampat, jekk jogħġbok irreferi għall-QRD annotata bħala gwida.]
English: An increased risk of arterial and venous thrombotic and thrombo-embolic events, including myocardial infarction, stroke, transient ischemic attacks, venous thrombosis and pulmonary embolism has been observed in women using CHCs, which are discussed in more detail in section 4.4.
Maltese: Żieda fir-riskju ta' avvenimenti trombotiċi u tromboemboliċi fl-arterji u l-vini, li jinkludu infart mijokardijaku, puplesija, attakki iskemiċi temporanji, trombożi fil-vini u emboliżmu pulmonari, ġiet osservata f'nisa li jużaw CHCs, u huma diskussi f'aktar dettall f'sezzjoni 4.4.
English: It is particularly important to read the symptoms of a blood clot - see Section 2 “Blood clots”).
Maltese: Hu speċjalment importanti li taqra s-sintomi ta' embolu tad-demm - ara Sezzjoni 2 "Emboli taddemm").
English: • if you have systemic lupus erythematosus (SLE -; a disease affecting your natural defence system);
Maltese: • jekk għandek lupus eritematosus sistemiku (SLE [systemic lupus erythematosus] - marda li taffettwa s-sistema ta' difiża naturali tiegħek);
English: Risk factor
Maltese: Fattur ta' riskju
English: • If you have varicose veins.
Maltese: • Jekk għandek vini varikużi.
English: Inconsistent results on the risk of VTE with [Invented name] compared with CHCs that contain levonorgestrel have been found (with relative risk estimates ranging from no increase, RR=0.96, to an almost 2 fold increase, RR=1.90).
Maltese: Instabu riżultati mhux konsistenti dwar ir-riskju ta' VTE b'[Isem ivvintat] imqabbla ma' CHCs li fihom levonorgestrel (bi stimi tar-riskju relattiv li jvarjaw minn l-ebda żieda, RR = 0.96, għal żieda ta' kważi d-doppju, RR = 1.90).
English: • if a member of your immediate family has had a heart attack or stroke at a young age (less then about 50).
Maltese: • jekk membru tal-familja immedjata tiegħek kellu attakk tal-qalb jew puplesija ta' età żgħira (inqas minn madwar 50 sena).
English: Women should be advised that hormonal contraceptives do not protect against HIV infections (AIDS) and other sexually transmitted diseases.
Maltese: In-nisa għandhom jingħataw parir li kontraċettivi ormonali ma jipproteġux kontra infezzjonijiet tal-HIV (AIDS) u mard ieħor li jiġi trasmess sesswalment.
English: Not yet known.
Maltese: Għadu mhux magħruf.
English: in the arteries (referred to as an ‘arterial thrombosis', ‘arterial thromboembolism' or ATE).
Maltese: fl-arterji (magħrufa bħala ‘trombożi fl-arterji', ‘tromboemboliżmu fl-arterji' jew ATE).
English: ANNEX III.D - drospirenone containing combined hormonal contraceptives
Maltese: ANNESS III.D - kontraċettivi ormonali kombinati li fihom drospirenone
English: ANNEX III.G - norgestimate containing combined hormonal contraceptives
Maltese: ANNESS III.G - kontraċettivi ormonali kombinati li fihom norgestimate
English: Your risk is higher:
Maltese: Irriskju tiegħek hu ogħla:
English: ANNEX III.E - etonogestrel containing combined hormonal contraceptives
Maltese: ANNESS III.E - kontraċettivi ormonali kombinati li fihom etonogestrel
English: The increased risk of thromboembolism in pregnancy, and particularly the 6 week period of the puerperium, must be considered (for information on “Pregnancy and lactation” see section 4.6).
Maltese: Iż-żieda fir-riskju ta' tromboemboliżmu fit-tqala, u b'mod partikulari l-perjodu ta' 6 ġimgħat ta' wara lħlas, għandu jiġi kkunsidrat (għal informazzjoni dwar “Tqala u treddigħ” ara sezzjoni 4.6.
English: kg/m²)
Maltese: ta' iktar minn 30 kg/m²);
English: Obesity (body mass index over 30 kg/m²)
Maltese: Ħxuna żejda (indiċi tal-piż tal-ġisem ta' iktar minn 30 kg/m²);
English: Section 4.8 - Undesirable effects [This following wording should be reflected in this section]
Maltese: Sezzjoni 4.8 - Effetti mhux mixtieqa [Il-kitba li ġejja għandha tiġi riflessa f'din is-sezzjoni]
English: ANNEX III.F - gestodene containing combined hormonal contraceptives
Maltese: ANNESS III.F - kontraċettivi ormonali kombinati li fihom gestodene
English: 1 Mid-point of range of 5-7 per 10,000 WY, based on a relative risk for CHCs containing levonorgestrel versus non-use of approximately 2.3 to 3.6
Maltese: 1 In-nofs ta' medda ta' 5-7 minn kull 10,000 WY, ibbażat fuq riskju relattiv għal CHCs li fihom levonorgestrel kontra nuqqas ta' użu ta' madwar 2.3 sa 3.6
English: [Invented name] is contraindicated if a woman has multiple risk factors that put her at high risk of venous thrombosis (see section 4.3).
Maltese: [isem ivvintat] hu kontraindikat jekk mara jkollha fatturi multipli ta' riskju li jpoġġuha f'riskju għoli ta' trombożi fil-vini (ara sezzjoni 4.3).
English: • if you have Crohn's disease or ulcerative colitis (chronic inflammatory bowel disease);
Maltese: • jekk għandek il-marda ta' Crohn jew kolite ulċerattiva (mard infjammatorju kroniku tal-imsaren);
English: Blood clots can develop in veins (referred to as a ‘venous thrombosis', ‘venous thromboembolism' or VTE)
Maltese: Emboli tad-demm jistgħu jiżviluppaw fil-vini (magħrufa bħala ‘trombożi fil-vini', ‘tromboemboliżmu fil-vini' jew VTE)
English: Products that contain levonorgestrel, norgestimate or norethisterone are associated with the lowest risk of VTE.
Maltese: Prodotti li jkun fihom levonorgestrel, norgestimate jew norethisterone huma assoċjati maliktar riskju baxx ta' VTE.
English: Symptoms of myocardial infarction (MI) can include: - pain, discomfort, pressure, heaviness, sensation of squeezing or fullness in the chest, arm, or below the breastbone; - discomfort radiating to the back, jaw, throat, arm, stomach; - feeling of being full, having indigestion or choking; - sweating, nausea, vomiting or dizziness; - extreme weakness, anxiety, or shortness of breath; - rapid or irregular heartbeats.
Maltese: Sintomi ta' infart mijokardijaku (MI - myocardial infarction) jistgħu jinkludu: - uġigħ, skumdità, pressjoni, toqla, sensazzjoni ta' għafis jew tħossok mimli fis-sider, driegħ, jew taħt in-nofs tal-kustilji; - skumdità li tinfirex għad-dahar, xedaq, gerżuma, driegħ jew stonku; - tħossok qisek mimli, ikollok indiġestjoni jew tifga; - għaraq, dardir, rimettar jew sturdament; - dgħufija estrema, ansjetà, jew qtugħ ta' nifs; - taħbit tal-qalb mgħaġġel jew irregolari.
English: • If a blood clot travels from the leg and lodges in the lung it can cause a pulmonary embolism.
Maltese: • Jekk embolu tad-demm jivvjaġġa mir-riġel u jeħel fil-pulmun, jista' jikkawża emboliżmu pulmonari.
English: • if you have (or have ever had) a blood clot in a blood vessel of your legs (deep vein thrombosis, DVT), your lungs (pulmonary embolus, PE) or other organs;
Maltese: • jekk għandek (jew qatt kellek) embolu tad-demm f'xi kanal tad-demm f'riġlejk (trombożi filvini tal-fond, DVT - deep vein thrombosis), fil-pulmun (embolu fil-pulmun, PE - pulmonary embolus) jew f'organi oħrajn;
English: ANNEX III.B - desogestrel containing combined hormonal contraceptives
Maltese: ANNESS III.B - kontraċettivi ormonali kombinati li fihom desogestrel
English: • if you know you have a disorder affecting your blood clotting - for instance, protein C deficiency, protein S deficiency, antithrombin-III deficiency, Factor V Leiden or antiphospholipid antibodies;
Maltese: • jekk taf li għandek disturb li jaffettwa t-tagħqid tad-demm tiegħek - pereżempju, defiċjenza ta' proteina Ċ, defiċjenza ta' proteina S, defiċjenza ta' antithrombin-III, antikorpi ta' Fattur V Leiden jew kontra l-fosfolipidi;
English: This corresponds to between about 6 and 12 VTEs in a year out of 10,000 women who use [Invented name].
Maltese: Dan jikkorrispondi għal bejn madwar 6 u 12-il VTEs f'sena minn 10,000 mara li jużaw [Isem ivvintat].
English: Products that contain levonorgestrel, norgestimate (including [invented name]) or norethisterone are associated with the lowest risk of VTE.
Maltese: Prodotti li jkun fihom levonorgestrel, norgestimate (li jinkludu [isem ivvintat]) jew norethisterone huma assoċjati mal-iktar riskju baxx ta' VTE.
English: Other medical conditions associated with VTE
Maltese: Kondizzjonijiet mediċi oħrajn assoċjati ma' VTE
English: Symptoms of pulmonary embolism (PE) can include: - sudden onset of unexplained shortness of breath or rapid breathing; - sudden coughing which may be associated with haemoptysis; - sharp chest pain; - severe light headedness or dizziness; - rapid or irregular heartbeat.
Maltese: Sintomi ta' emboliżmu pulmonari (PE - pulmonary embolism) jistgħu jinkludu: - bidu għal għarrieda ta' qtugħ ta' nifs jew nifs mgħaġġel inspjegabbli; - sogħla għal għarrieda li tista' tkun assoċjata ma' emoptisi; - uġigħ qawwi fis-sider; - mejt jew sturdament sever; - taħbit tal-qalb mgħaġġel jew irregolari.
English: - Out of 10,000 women who are using a combined hormonal contraceptive that contains levonorgestrel, norethisterone, or norgestimate about 5-7 will develop a blood clot in a year.
Maltese: - Minn 10,000 mara li jkunu qed jużaw kontraċettiv ormonali kombinat li fih levonorgestrel, norethisterone, jew norgestimate, madwar 5-7 se jiżviluppaw embolu tad-demm f'sena.
English: • sudden trouble walking, dizziness, loss of balance or coordination;
Maltese: • ikollok problemi f'daqqa biex timxi, sturdament, telf talbilanċ jew koordinazzjoni;
English: Rarely, there may be serious lasting effects or, very rarely, they may be fatal.
Maltese: B'mod rari, jista' jkun hemm effetti serji fittul jew, b'mod rari ħafna, jistgħu jkunu fatali.
English: Prior to the initiation or reinstitution of [invented name] a complete medical history (including family history) should be taken and pregnancy must be ruled out.
Maltese: Qabel il-bidu jew bidu mill-ġdid ta' [isem ivvintat] għandha tittieħed storja medika kompluta (li tinkludi l-istorja medika tal-familja), u t-tqala trid tiġi eskluża.
English: • The use of combined hormonal contraceptives has been connected with an increase in the risk of blood clots in the vein (venous thrombosis).
Maltese: • L-użu ta' kontraċettivi ormonali kombinati ġie assoċjat ma' żieda fir-riskju ta' emboli tad-demm filvina (trombożi fil-vini).
English: Prolonged immobilisation, major surgery, any surgery to the legs or pelvis, neurosurgery, or major trauma
Maltese: Immobilizzazzjoni fit-tul, operazzjoni maġġuri, kwalunkwe operazzjoni fissaqajn jew pelvi, kirurġija newroloġika, jew trawma maġġuri
English: Symptoms of ATE
Maltese: EMBOLI TAD-DEMM
English: 2 Mid-point of range of 5-7 per 10,000 WY, based on a relative risk for CHCs containing levonorgestrel versus non-use of approximately 2.3 to 3.6
Maltese: 2 Punt medju tal-firxa ta' 5-7 għal kull 10,000 WY, ibbażat fuq riskju relattiv ta' CHCs li fihom levonorgestrel kontra l-ebda użu ta' madwar 2.3 sa 3.6